Description
OVERVIEWProduct overview
Pinealon is a short peptide bioregulator studied in the same Russian research tradition as Epitalon, with an emphasis on neuronal tissue.
Reported endpoints concern oxidative stress markers and neuronal survival in hypoxia models.
All published work is preclinical or investigational. This material is supplied as a laboratory reference compound and is not authorised as a medicine in Ireland, the UK or the EU.
SUPPLY IN IRELANDPinealon Ireland — supplied to research laboratories
Research groups across Ireland buy Pinealon from Kensington Laboratories as a lyophilised Pinealon peptide, released only against a batch-matched certificate of analysis. Every vial of high purity Pinealon is verified by HPLC and LC-MS before it leaves the facility, so laboratories ordering Pinealon in Ireland receive material with documented purity and identity.
Laboratory Pinealon is packed for controlled storage and sent by tracked delivery in 3–5 days to Dublin, Cork, Galway, Limerick and the rest of Ireland. Delivery costs €9.90 per order. Teams planning Pinealon research can review the specifications, certificate of analysis and reference list on this page before ordering.
Institutions searching for Pinealon peptide suppliers in Ireland typically compare purity, batch documentation and delivery times. Each of those is published here: a 99% HPLC purity specification, a certificate matched to the batch code on your vial, and tracked delivery in 3–5 days.
Pinealon is supplied strictly for laboratory research use only. It is not a medicine and is not for human or veterinary consumption.
SPECIFICATIONSProduct specifications
- Purity: ≥ 99% (HPLC)
- Appearance: White lyophilised powder
- Quantity: 10 mg per vial
- Sequence: Glu-Asp-Arg
- Peptide class: Synthetic tripeptide bioregulator
- Also known as: EDR peptide
- Solubility: Soluble in bacteriostatic or sterile water
- Storage temperature: Store at 2–8°C; long-term −20°C, protected from light
- Shelf life: 24 months lyophilised; 30 days reconstituted at 2–8°C
- Manufacturing standard: ISO 9001 facility, GMP-aligned solid-phase synthesis
- Batch information: Batch number and expiry printed on every vial label
RESEARCHResearch overview
The following summary is provided for educational and scientific context only. It describes what has been observed in published laboratory and animal studies and does not represent established clinical outcomes, medical advice or a claim of efficacy in humans.
Background
Pinealon is a short peptide bioregulator studied in the same Russian research tradition as Epitalon, with an emphasis on neuronal tissue.
Reported endpoints concern oxidative stress markers and neuronal survival in hypoxia models.
All published work is preclinical or investigational. This material is supplied as a laboratory reference compound and is not authorised as a medicine in Ireland, the UK or the EU.
Current research areas
Published investigation clusters around a small number of biological themes. Each remains experimental and none has been established as a therapeutic effect in humans.
- Neuronal culture survival under hypoxia
- Oxidative stress marker measurement
- Cognitive endpoints in rodent models
- Gene expression regulation studies
Scientific context and proposed mechanisms
Authors propose direct interaction with DNA regulatory regions altering expression of stress-response genes, a mechanism common to the short peptide bioregulator literature and not yet independently established.
Interpreting the evidence
Most published work in this area uses cell culture or rodent models with small group sizes and short observation windows. Independent replication varies considerably between compounds, and results are sensitive to species, route, dose and endpoint.
There is no regulatory-approved human protocol for this compound. Any laboratory protocol should be defined by the model under study, institutional ethical approval, appropriate controls and predefined endpoints.
References
CERTIFICATE OF ANALYSISIndependent batch testing
Every released batch is independently tested. Match the batch number on the vial to the certificate published online.
- Batch number
- KL-PINEALON-2409A
- Testing laboratory
- Janoshik Analytical, s.r.o.
- Date tested
- 12 August 2026
- Reported purity
- 99.72%
- Method
- RP-HPLC with UV detection at 214 nm, confirmed by LC-MS
The independent result for this batch is summarised above. Contact the laboratory team if you need the full report for this batch.
